HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

KR33426

structure in first source

Also Known As:

(2-(2,5-dichlorophenyl)-5-methyloxazol-4yl)carbonylguanidine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amidines: 14
  - Guanidines: 29
    - KR33426: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Oxazoles: 89
      - KR33426: 1

Experts

1.	Han, Seung-Hyun: 1 article (10/2011)
2.	Kim, Hyun-Sun: 1 article (10/2011)
3.	Lee, Geun-Hee: 1 article (10/2011)
4.	Lee, Sunkyung: 1 article (10/2011)
5.	Moon, Eun-Yi: 1 article (10/2011)
6.	Oh, Jin-Mi: 1 article (10/2011)
7.	Yang, Young: 1 article (10/2011)
8.	Yi, Kyu Yang: 1 article (10/2011)
9.	Yoon, Won-Kee: 1 article (10/2011)

Related Diseases

1.

Systemic Lupus Erythematosus (Libman-Sacks Disease)

10/15/2011 - "Data show that KR33426 inhibits BAFF-BAFF-R interactions and it is effective on the treatment of systemic lupus erythematosus-like symptom in MRL(lpr/lpr) mice. "
10/15/2011 - "In addition, we examined whether KR33426 was effective on the treatment of systemic lupus erythematosus-like symptom in MRL(lpr/lpr) mouse. "
10/15/2011 - "KR33426, [2-(2,5-dichlorophenyl)-5-methyloxazol-4yl]carbonylguanidine, is a novel compound to be effective on mouse systemic lupus erythematosus."